Gulf Oil Lubricants India Limited Reports Record Q3 FY2026 with All-Time High Volumes and Revenue
Gulf Oil Lubricants India Limited announced a record performance for the third quarter ending December 31, 2025, achieving all-time high…
Aditya Birla Capital Transcript of Conference Call on Financial Results for Q3 FY2026
Aditya Birla Capital has released the official transcript of its conference call discussing the financial results for the quarter and nine…
Lloyds Engineering Works Limited Promoter Entities Transfer 3.77% Equity Stake via Block Deal
Entities within the Promoter and Promoter Group of Lloyds Engineering Works Limited executed a significant share transfer via a ‘Block…
AARTI PHARMALABS Announces Interim Dividend for FY 2024-25 and Sets Record Date
Aarti Pharmalabs has declared an Interim Dividend of ₹1.5/- per Equity Share (equivalent to 30% on the face value of ₹5/-) for the Financial…
Bata India Q3 FY26 Results Show 10% Underlying Profit Growth Driven by Premiumization and Strategic Levers
Bata India announced strong results for the quarter ending December 31, 2025 (Q3FY26). Underlying profit before exceptional items grew by 10%…
AARTI PHARMALABS Board Approves Unaudited Financial Results and Interim Dividend for Q3 FY2026
Aarti Pharmalabs announced the unaudited financial results for the quarter and nine months ended December 31, 2025, following a Board meeting…
Embassy Developments Limited Monitoring Agency Report on Preferential Issue Proceeds Utilization up to Q3 FY26
Embassy Developments Limited has submitted the Monitoring Agency Report for the quarter ending December 31, 2025 (Q3FY26), prepared by CARE…
Gulf Oil Lubricants India Limited Board Declares Interim Dividend and Approves Q3 FY2025-26 Results
Gulf Oil Lubricants India Limited’s Board of Directors has approved the Unaudited Financial Results for the third quarter and nine…
Sterlite Technologies Limited Board Approves Issuance of Warrants to Promoter for Capital Raise
Sterlite Technologies Limited announced an upcoming Extra Ordinary General Meeting (EGM) scheduled for Wednesday, March 04, 2026, to seek…
AARTI PHARMALABS Board Approves Q3 FY26 Unaudited Results and Interim Dividend of ₹1.50 Per Share
The Board of Directors of Aarti Pharmalabs approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine…